Preclinical Toxicology Services: Inspected. Certified. Trusted.

Take a behind-the-scenes look at our state-of-the-art preclinical toxicology facilities in China and the US. Supporting drug development from discovery to clinical phases, we offer both non-GLP and GLP toxicology studies tailored to your needs.

Our services include general toxicology, DART, safety pharmacology, genetic toxicology, and immunogenicity evaluations, covering all modalities such as small molecules, biologics, CGT, as well as medical devices. With regular inspections by the FDA, OECD, NMPA, and MHRA, we ensure strict global compliance.

Pharmaron’s purpose-built facilities streamline workflows with in-house histology, pathology, and bioanalysis, delivering high-quality data on tight timelines. Our clients collaborate closely with our scientists to fast-track preclinical toxicology studies for IND filings.

Watch our video to explore how our preclinical toxicology services can help you achieve your drug development goals effectively.